Pharmalot… Pharmalittle… Good Morning

Rise and shine. Another busy day is on the way. And a hectic one it is this morning here on the Pharmalot corporate campus, where we are, once again, hustling short people to schoolhouses and encouraging the official mascosts to fertilize the weeds as quickly as possible. As always, there is no time to waste. So please join us for a cup of stimulation and a smattering of interesting items to get going. Hope your day goes well and drop us a line if you hear anything interesting… Pfizer To Shuffle Units Prompting Break-Up Speculation (Bloomberg News) Pharma Bets On New Blockbusters In 2013 (Reuters) Pfizer Considers Buying Strides Arcolab Injectables Unit (Bloomberg News) AstraZeneca Neuroscience Unit Inks Deal With Vanderbilt University (Boston Business Journal) Otsuka Can Block Generic Abilify As Court Rejects Appeal (Bloomberg News) UK’s NICE Backs Two Breast Cancer Meds (Reuters) New Guideline For Minimum Trial Protocol Content (Outsourcing Pharma) Pharmacies To Maintain Hold On Dispensing In Denmark (Copenhagen Post) EDITOR’S NOTE: Please check this post for updates
Source: Pharmalot - Category: Pharma Commentators Authors: Tags: Uncategorized Abilify Apotex AstraZeneca Breast Cancer Otsuka Pharmaceutical Pfizer Pharmacies Strides Arcolab Vanderbilt University Source Type: blogs